Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - tamsulosin hydrochloride, quantity: 400 microgram - tablet, modified release - excipient ingredients: quinoline yellow; purified talc; polyethylene oxide; cochineal; microcrystalline cellulose; magnesium stearate; hyprolose; butylated hydroxytoluene; macrogol 400; titanium dioxide; iron oxide black; hypromellose; colloidal anhydrous silica - for the relief of lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia (bph).

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

waymade australia pty limited - levothyroxine sodium, quantity: 0.1 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; sunset yellow fcf aluminium lake; magnesium stearate; colloidal anhydrous silica; quinoline yellow aluminium lake; purified talc; pregelatinised starch - thyrox is indicated for the management of demonstrated thyroid hormone deficiency.,thyrox is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Malta - Ingliż - Medicines Authority

p & d pharmaceuticals limited 38 woolmer way, bordon hampshire gu35 9qf, united kingdom - hydroxychloroquine sulfate - film-coated tablet - hydroxychloroquine sulfate 200 mg - antiprotozoals

Malta - Ingliż - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - hydroxychloroquine sulfate - film-coated tablet - hydroxychloroquine sulfate 200 mg - antiprotozoals

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

pharmaco australia ltd - mefloquine hydrochloride, quantity: 274.09 mg (equivalent: mefloquine, qty 250 mg) - tablet, uncoated - excipient ingredients: ammonium alginate; crospovidone; lactose monohydrate; magnesium stearate; microcrystalline cellulose; purified talc; maize starch; poloxamer - malaria treatment: lariam is indicated for the treatment of acute attacks of malaria due to p.falciparum infection resistant to conventional antimalarial drugs. following therapy of mixed p.falciparum/p.vivax malaria with lariam relapse prophylaxis with an 8-aminoquinoline derivative (e.g. primaquine) should be considered in order to eliminate liver forms of p.vivax. malaria prophylaxis: for travellers to countries with documented chloroquine and antifolate combination ( [sulfadoxine/pyrimethamine] / [dapsone/pyrimethamine] ) resistant p.falciparum malaria, who are considered to be at high risk for malaria in view of their residence or travel (of up to 3 months duration) through rural areas (between the dusk to dawn period). for travellers hypersensitive to sulphonamides and sulphones, who are considered to be at high risk for malaria in view of their residence or travel (of up to 3 months duration) through rural areas, (between the dusk to dawn period) in countries with high level chloroquine-resistant p.fal

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - quinine bisulfate heptahydrate, quantity: 300 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; sodium starch glycollate; carnauba wax; magnesium stearate; lactose monohydrate; colloidal anhydrous silica; purified talc; microcrystalline cellulose; povidone; titanium dioxide; hypromellose; macrogol 4000 - treatment of malaria due to strains of p. falciparum resistant to chloroquine and the related 4-aminoquinolines.

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

viatris limited - phenytoin 50mg; phenytoin 50mg; phenytoin 50mg - chewable tablet - 50 mg - active: phenytoin 50mg excipient: magnesium stearate purified talc quinoline yellow saccharin sodium spearmint flavour natural 11584 sucrose sunset yellow fcf wheat starch active: phenytoin 50mg excipient: spearmint flavour natural 11584 magnesium stearate maize starch purified talc quinoline yellow saccharin sodium sucrose sunset yellow fcf active: phenytoin 50mg excipient: confectioner's sugar magnesium stearate purified talc quinoline yellow saccharin sodium spearmint flavour natural 11584 sunset yellow fcf - dilantin is indicated for the control of grand mal and psychomotor seizures. dilantin will prevent or effectively decrease the incidence and severity of convulsive seizures in a high percentage of cases, with patients exhibiting little tendency to become resistant to its action. besides its effectiveness in controlling seizures, dilantin frequently improves the mental condition and outlook of epileptic patients and there is also increasing evidence that dilantin is valuable in the prevention of seizures occurring during or after neurosurgery. phenytoin serum level determinations may be necessary for optimal dosage adjustments.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - phenytoin, quantity: 50 mg - tablet, chewable - excipient ingredients: quinoline yellow; saccharin sodium; magnesium stearate; purified talc; sunset yellow fcf; flavour; maize starch; sucrose - dilantin is indicated for the control of grand mal and psychomotor seizures. dilantin will prevent or effectively decrease the incidence and severity of convulsive seizures in a high percentage of cases, with patients exhibiting little tendency to become resistant to its action. besides its effectiveness in controlling seizures, dilantin frequently improves the mental condition and outlook of epileptic patients and there is also increasing evidence that dilantin is valuable in the prevention of seizures occurring during or after neurosurgery. phenytoin serum level determinations may be necessary for optimal dosage adjustments (see dosage and administration).

Stati Uniti - Ingliż - NLM (National Library of Medicine)

h. w. naylor company inc. - 8-hydroxyquinoline .14% - chapped teats, minor cuts, scrapes, scratches, chafes, windburn, sunburn.

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - glacial acetic acid 0.94%{relative}; oxyquinoline 0.025%{relative}; ricinoleic acid 0.75%{relative} (as 0.802%w/w castor oil bp) - vaginal gel - active: glacial acetic acid 0.94%{relative} oxyquinoline 0.025%{relative} ricinoleic acid 0.75%{relative} (as 0.802%w/w castor oil bp) excipient: acacia glycerol ovalbumin potassium acid tartrate potassium hydroxide propyl hydroxybenzoate purified water stannous chloride tragacanth